Home > Proceedings in Haematology > Proceedings of the 4th European Congress Controversies in Leukemia

Proceedings of the 4th European Congress Controversies in Leukemia


The 4th European Congress Controversies in Leukemias 20-21 November 2023, Brussels, Belgium

Table of Contents



Definitions of acute myeloid leukaemia and their clinical significance according to the WHO 2022 and ICC classification

Is allogeneic transplantation necessary in acute myeloid leukaemia of intermediate risk in the first complete remission?

Why we should opt for continuous therapy in chronic lymphocytic leukaemia?

Conference Proceedings

Definitions of acute myeloid leukaemia and their clinical significance according to the WHO 2022 and ICC classification

Advances and remaining challenges in adult acute lymphoblastic leukaemia

Drug-based maintenance strategies post-allogeneic stem cell transplantation – are we there yet (and will we be)?

Therapeutic strategies in TP53 AML not eligible to intensive chemotherapy

Is allogeneic transplantation necessary in acute myeloid leukaemia of intermediate risk in the first complete remission?

Immunotherapeutic strategies after allogeneic stem cell transplantation

Why we should opt for continuous therapy in chronic lymphocytic leukaemia?

Acute myeloid leukaemia: First debate on leukaemia biology

Therapeutic strategies in high-risk acute myeloid leukaemia eligible for intensive chemotherapy

site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com